Both Medtronic and Abbott have dropped in 2026, and those declines reshuffled the math on yield, valuation, and long-term growth in ways that push retirement investors toward a clear but maybe surprising choice.
Park National Corp OH lowered its position in shares of Medtronic PLC (NYSE: MDT) by 12.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 102,898 shares of the medical technology company's stock after selling 13,988 shares during the period. Park National
Argent Capital Management LLC lowered its position in Medtronic PLC (NYSE: MDT) by 4.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 174,092 shares of the medical technology company's stock after selling 7,596 shares during the quarter. Argent Capital Management LLC's holdings
MassMutual Private Wealth and Trust FSB increased its position in shares of Medtronic PLC (NYSE: MDT) by 14.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 149,708 shares of the medical technology company's stock after buying an additional 19,315 shares during the period.
One of these stocks lost nearly a fifth of its value over the past year, another nearly doubled, and both still handed shareholders a bigger check. Find out whether the dividends behind these very different charts are built to last.
Medtronic has raised its dividend for 49 straight years while the stock quietly lost a fifth of its value, but something in the operating room just changed the entire conversation about why investors should own it.
Medtronic PLC (NYSE: MDT - Get Free Report) saw unusually large options trading on Thursday. Stock investors purchased 24,238 put options on the company. This represents an increase of 45% compared to the average daily volume of 16,739 put options. Key Medtronic News Here are the key news stories impacting Medtronic this week: Positive Sentiment: TD